These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 23441126
41. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen PL. Int J Cancer; 2002 Apr 20; 98(6):946-51. PubMed ID: 11948478 [Abstract] [Full Text] [Related]
42. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. Harris AR, Perez MJ, Munson JM. BMC Cancer; 2018 Jul 06; 18(1):718. PubMed ID: 29976154 [Abstract] [Full Text] [Related]
43. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K. Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015 [Abstract] [Full Text] [Related]
46. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Jones D, Xu Z, Zhang H, He Y, Kluger MS, Chen H, Min W. Arterioscler Thromb Vasc Biol; 2010 Dec 01; 30(12):2553-61. PubMed ID: 20864667 [Abstract] [Full Text] [Related]
47. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation. Lee E, Rosca EV, Pandey NB, Popel AS. Int J Biochem Cell Biol; 2011 Dec 01; 43(12):1812-21. PubMed ID: 21920451 [Abstract] [Full Text] [Related]
48. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. Matsumoto M, Roufail S, Inder R, Caesar C, Karnezis T, Shayan R, Farnsworth RH, Sato T, Achen MG, Mann GB, Stacker SA. Clin Exp Metastasis; 2013 Aug 01; 30(6):819-32. PubMed ID: 23591595 [Abstract] [Full Text] [Related]
49. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis. Henno A, Blacher S, Lambert CA, Deroanne C, Noël A, Lapière C, de la Brassinne M, Nusgens BV, Colige A. J Dermatol Sci; 2010 Mar 01; 57(3):162-9. PubMed ID: 20071151 [Abstract] [Full Text] [Related]
50. Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator. Liersch R, Hirakawa S, Berdel WE, Mesters RM, Detmar M. Int J Oncol; 2012 Dec 01; 41(6):2073-8. PubMed ID: 23076721 [Abstract] [Full Text] [Related]
51. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]. Huang JH, Li Y, Liu L, Yang HC, Hai J, Tang LL, Hu TH. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 01; 31(1):36-9, 51. PubMed ID: 16562672 [Abstract] [Full Text] [Related]
52. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P. Breast Cancer Res Treat; 2006 Sep 01; 99(2):135-41. PubMed ID: 16555123 [Abstract] [Full Text] [Related]
54. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer. Lala PK, Nandi P, Majumder M. Cancer Metastasis Rev; 2018 Sep 01; 37(2-3):369-384. PubMed ID: 29858743 [Abstract] [Full Text] [Related]
56. Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. Larrieu-Lahargue F, Welm AL, Bouchecareilh M, Alitalo K, Li DY, Bikfalvi A, Auguste P. PLoS One; 2012 Sep 01; 7(6):e39540. PubMed ID: 22761819 [Abstract] [Full Text] [Related]
57. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin. Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ. Int J Oncol; 2012 Nov 01; 41(5):1762-72. PubMed ID: 22922710 [Abstract] [Full Text] [Related]
58. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Tutunea-Fatan E, Majumder M, Xin X, Lala PK. Mol Cancer; 2015 Feb 10; 14():35. PubMed ID: 25744065 [Abstract] [Full Text] [Related]
59. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells. Qin TT, Xu GC, Qi JW, Yang GL, Zhang K, Liu HL, Xu LX, Xiang R, Xiao G, Cao H, Wei Y, Zhang QZ, Li LY. J Pathol; 2015 Nov 10; 237(3):307-18. PubMed ID: 26096340 [Abstract] [Full Text] [Related]
60. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW, Lien JC, Kuo SC, Huang TF. Carcinogenesis; 2012 May 10; 33(5):1022-30. PubMed ID: 22436611 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]